- Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2025
Progressive Markets published a report, Pain Management Drugs Market - Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2025. As per the report, the market was valued at $ 53267.0 million in 2014 and is likely to garner $ 77255.7 million in 2025, growing at a CAGR of 3.87% during the forecast period.
Pain is an unpleasant physical sensation arising from tissue damage or illness. Moreover, many diseases such as stomach ulcer, fibromyalgia, osteoarthritis, chronic arthritis, multiple sclerosis, diabetic neuropathy, and cancer cause pain. The duration of a pain can be short or long. Short-term pain is referred to as acute pain while long-term pain is referred to as chronic pain. Acute pain is a sudden occurrence of pain, while chronic pain occurs due to the aging of bones & joints, nerve damage, or injury. In order to manage pain, several drugs are available in the market. These drugs either reduce or treat the pain, causing relief to the body.
Market Drivers and Restraints:
The report offers a detailed understanding of the drivers and restraints influencing the pain management drugs market. The industry is driven by the rise in incidences of chronic diseases, favorable regulatory scenario, and an increase in the geriatric population. In addition, advancements in the development of drugs as well as the presence of many untapped markets in the emerging economies provide opportunities for the growth of the market. Nonetheless, availability of alternative therapies, drug exploitation, and patent expiration of prescription drugs act as obstacles to the growth of the market.
The report analyzes the pain management drugs market based on the drug class, indication, and geography. Based on type, the industry is bifurcated into NSAIDs, anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and non-narcotic analgesics. Based on indication, the market is classified as arthritic pain, neuropathic pain, cancer pain, chronic back pain, post-operative pain, migraine, and fibromyalgia. Geographically, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. The pain management drugs market analysis in North America is covered for the U.S., Canada, and Mexico. The market study in Europe covers Germany, France, UK, Italy, Spain, and the rest of Europe. In Asia-Pacific, the market is analyzed across Japan, China, Australia, India, South Korea, Taiwan, and the rest of Asia-Pacific. The market analysis in LAMEA covers Brazil, Saudi Arabia, Republic of South Africa, and the rest of LAMEA.
Key Market Players:
The study includes a mention of the emerging players operating in the pain management drugs market. They adopt strategies such as mergers and acquisitions, launches and more to survive and grow in the marketplace. The players in the industry include Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc.
Key Benefits from the Report:
The pain management drugs market report offers a comprehensive analysis of the industry with the help of pain management drugs market size, pain management drugs market share, pain management drugs market outlook, pain management drugs market forecast, pain management drugs market trends, market dynamics, Porters Analysis, pain management drugs industry statistics, and major competitors. The report offers the market size to help understand the current and future potential of the market. The market dynamics are explained by offering details on aspects such as the drivers, restraints, and opportunities. The industry statistics helps in assessing the market share and potential. The market share analysis assesses the level of competition within the industry. An analysis of the various aspects of the key industry players such as their financial strategies, recent developments, and summary of their products and services are offered in the study. The current trends and estimations help identify the profitable investment pockets. The Porters Five Forces analysis, which comprises the bargaining power of buyers, bargaining power of suppliers, threat from substitutes, threat of new entrants, and industry rivalry, helps determine the level of competition in the market.
Progressive Markets published a report, Isopropyl Ethyl Thionocarbamate (IPETC) Market - Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2022, which says that the market was valued at around 97.7 million ... Read More >>